Phase II trial of chemoradiotherapy using weekly gemcitabine (GEM) in patients (pts) with locally advanced pancreatic cancer (PC). Final results No significant financial relationships to disclose.
Retrospective cohort study on the risk factors of admission due to serious adverse events during S-1 (tegaful, gimeracil, oteracil potassium) containing chemotherapy for gastric cancer. Background: An ...
AMA Updates CPT Category II Code List The American Medical Association has released an update to the CPT Category II code list. The update contains many revisions, significant new codes and deleted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results